🇺🇸 FDA

Drug profile · INN

oxcarbazepine

OXCARBAZEPINE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

oxcarbazepine (OXCARBAZEPINE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN oxcarbazepine
Brand OXCARBAZEPINE
Route ORAL
Formulation TABLET, EXTENDED RELEASE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 11896599

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11166960

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10220042

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9855278

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9370525

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9351975

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9119791

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9119792

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is oxcarbazepine?

oxcarbazepine (OXCARBAZEPINE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for oxcarbazepine?

OXCARBAZEPINE is a marketed brand name for oxcarbazepine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of oxcarbazepine?

oxcarbazepine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.